PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18505831-0	2008	Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.	sodium arsenite	0-15	nuclear receptor subfamily 0 group B member 2	Homo sapiens	31-51	
18505831-10	2008	Results from our study suggest that sodium arsenite induces SHP via AMPK to inhibit the expression of hepatic gluconeogenic genes and also provide us with a novel molecular mechanism of arsenite-mediated regulation of hepatic glucose homeostasis.	sodium arsenite	36-51	nuclear receptor subfamily 0 group B member 2	Homo sapiens	60-63	
18505831-2	2008	In this study, we report that the sodium arsenite-induced gene expression of the small heterodimer partner (SHP; NR0B2), an atypical orphan nuclear receptor, regulates the expression of hepatic gluconeogenic genes.	sodium arsenite	34-49	nuclear receptor subfamily 0 group B member 2	Homo sapiens	81-106	
18505831-2	2008	In this study, we report that the sodium arsenite-induced gene expression of the small heterodimer partner (SHP; NR0B2), an atypical orphan nuclear receptor, regulates the expression of hepatic gluconeogenic genes.	sodium arsenite	34-49	nuclear receptor subfamily 0 group B member 2	Homo sapiens	108-111	
18505831-2	2008	In this study, we report that the sodium arsenite-induced gene expression of the small heterodimer partner (SHP; NR0B2), an atypical orphan nuclear receptor, regulates the expression of hepatic gluconeogenic genes.	sodium arsenite	34-49	nuclear receptor subfamily 0 group B member 2	Homo sapiens	113-118	
18505831-3	2008	Sodium arsenite augments hepatic SHP mRNA levels in an AMP-activated protein kinase (AMPK)-dependent manner.	sodium arsenite	0-15	nuclear receptor subfamily 0 group B member 2	Homo sapiens	33-36	
18505831-6	2008	We demonstrated the dose-dependent induction of SHP mRNA levels by sodium arsenite and repressed the forskolin/dexamethasone-induced gene expression of the key hepatic gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase).	sodium arsenite	67-82	nuclear receptor subfamily 0 group B member 2	Homo sapiens	48-51	
18505831-8	2008	Sodium arsenite inhibited the promoter activity of PEPCK and G6Pase, and this repression was abolished by small interfering (si)RNA SHP treatments.	sodium arsenite	0-15	nuclear receptor subfamily 0 group B member 2	Homo sapiens	132-135	
18505831-9	2008	The knockdown of SHP expression by oligonucleotide siRNA SHP or adenoviral siRNA SHP released the sodium arsenite-mediated repression of forskolin/dexamethasone-stimulated PEPCK and G6Pase gene expression in a variety of hepatic cell lines.	sodium arsenite	98-113	nuclear receptor subfamily 0 group B member 2	Homo sapiens	17-20